Personnel
Novavax names Dr. Penny Heaton chief medical officer
Published in Medical Letter on the CDC and FDA, November 5th, 2006
Heaton joins the company after a seven-year career at Merck & Co.'s Research Laboratories, where she served as senior director of Vaccines Clinical Research.
She will be responsible for all medical and regulatory affairs and will lead the clinical development programs for Novavax's pandemic and seasonal influenza vaccines. Heaton will report directly to Novavax President and Chief Executive Officer Dr. Rahul Singhvi.
While at Merck, Heaton, 42, oversaw the clinical development and global regulatory filings and approval process for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Colon Cancer
Intervention research aims to promote colorectal cancer screening - Food Safety
Effects of zearalenone on in utero development in rats was examined - Hepatitis C Vaccine
Hepatitis C immunization causes CD4+ immune escape and T cell failure in chimps - HIV/AIDS Screening
Sexually transmitted disease and HIV screening results of physician survey are reported - Human T Lymphotropic Virus
Natural history of viral markers of HTLV type I in Jamaica is presented - FDA
Data on FDA detailed by researchers at Royal Free and University College, Biomaterials and Tissue Engineering Center - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
